Skip to content

Step into the world’s first onco-neuro campus.

Integrating Oncology & Neuroscience Research

Step into the world’s first onco-neuro campus.

A new approach is needed to tackle cancer and brain diseases.

One in two people will face cancer. One in five will develop dementia. And for too many, there is still no cure. At Adore, oncology and neuroscience come together on one campus. By breaking down boundaries between disciplines, we accelerate discoveries and bring breakthroughs within reach.

 

Prof. dr. Geert Kazemier

With cancer, cells grow out of control. With brain diseases, the opposite happens: cells die off. Two extremes. And that contrast may hold the key to new answers.

Prof. dr. Geert Kazemier
Oncologic surgeon and co-founder of Adore

One roof. Two disciplines. The entire journey.

Researchers and clinicians in oncology and neurology work side by side in our Research & Diagnostics Center. They break down silos, share facilities, and challenge each other’s assumptions. The result is a constant exchange between scientific discovery and clinical experience, from the lab to the patient, and back again.

One roof. Two disciplines. The entire journey.

I hope Adore leads to new insights and helps bring better treatments to patients faster. Research changed my life. Thanks to researchers, I’m still here today.

Marianne Vink
Marianne Vink,
has cancer

Adore gives me greater hope for a cure for MS. By looking beyond their own fields, researchers may find the missing piece that leads to a breakthrough.

Reni de Boer
Reni de Boer,
has MS

Three goals. One shared mission.

Detecting disease earlier

The earlier we detect cancer or brain disease, the better the chances of successful treatment. Advanced imaging, biomarkers, and AI can help us diagnose disease sooner.

Personalized treatment

No two diseases are the same. By better understanding different disease subtypes, we can choose the right treatment path for each patient. More targeted care, with fewer side effects, and better outcomes.

Developing new therapies

For certain types of cancer, dementia, Parkinson’s, and MS, there is still no cure. We want to change that.

Help build the next breakthrough.

Adore is supported by a select group of people who want to be close to where breakthroughs happen. Entrepreneurs, families, and individuals who choose not to stand on the sidelines, but to help shape what comes next. Together, they form the Circles of Impact.

Help build the next breakthrough.
Robert Jan van Hamersveld

Adore is much more than a building. It is an investment in a new way of working together , one where oncology and neuroscience strengthen each other and accelerate breakthroughs for patients. Being able to contribute to that feels both meaningful and truly special.

Robert Jan van Hamersveld
Chair of the Executive Board of Newomij

Come see where breakthroughs happen.

Schedule an introductory meeting or a tour in our Research & Diagnostics Center.

Adore. A groundbreaking initiative by Amsterdam UMC.